Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.

Mortara L, Balza E, Bruno A, Poggi A, Orecchia P, Carnemolla B.

Front Immunol. 2018 Dec 18;9:2905. doi: 10.3389/fimmu.2018.02905. eCollection 2018. Review.

2.

Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles.

D'Andrea F, Nuti E, Becherini S, Cuffaro D, Husanu E, Camodeca C, De Vita E, Zocchi MR, Poggi A, D'Arrigo C, Cappello V, Gemmi M, Nencetti S, Chiappe C, Rossello A.

ChemMedChem. 2019 Jan 2. doi: 10.1002/cmdc.201800733. [Epub ahead of print]

PMID:
30600908
3.

Immunomodulatory properties of mesenchymal stromal cells: still unresolved "Yin and Yang".

Poggi A, Zocchi MR.

Curr Stem Cell Res Ther. 2018 Dec 4. doi: 10.2174/1574888X14666181205115452. [Epub ahead of print]

PMID:
30516112
4.

Tumor Vasculature Targeted TNFα Therapy: Reversion of Microenvironment Anergy and Enhancement of the Anti-tumor Efficiency.

Balza E, Carnemolla B, Orecchia P, Rubartelli A, Poggi A, Mortara L.

Curr Med Chem. 2018 Sep 4. doi: 10.2174/0929867325666180904121118. [Epub ahead of print]

PMID:
30182839
5.

Flow Cytometric Characterization of S-phase Fraction and Ploidy in Lymph Node Aspirates from Dogs with Lymphoma.

Miniscalco B, Poggi A, Martini V, Morello E, Sulce M, Melega M, Borrelli A, Tarducci A, Riondato F.

J Comp Pathol. 2018 May;161:34-42. doi: 10.1016/j.jcpa.2018.04.005. Epub 2018 Jun 1.

PMID:
30173856
6.

Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.

Camodeca C, Nuti E, Tosetti F, Poggi A, D'Arrigo C, Zocchi MR, Rossello A.

ChemMedChem. 2018 Oct 8;13(19):2119-2131. doi: 10.1002/cmdc.201800482. Epub 2018 Sep 12.

PMID:
30102846
7.

Investigation on silent bacterial infections in specimens from pregnant women affected by spontaneous miscarriage.

Contini C, Rotondo JC, Magagnoli F, Maritati M, Seraceni S, Graziano A, Poggi A, Capucci R, Vesce F, Tognon M, Martini F.

J Cell Physiol. 2018 Jan;234(1):100-107. doi: 10.1002/jcp.26952. Epub 2018 Aug 5.

PMID:
30078192
8.

Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.

Rossetti B, Di Giambenedetto S, Torti C, Postorino MC, Punzi G, Saladini F, Gennari W, Borghi V, Monno L, Pignataro AR, Polilli E, Colafigli M, Poggi A, Tini S, Zazzi M, De Luca A; Antiviral Response Cohort Analysis (ARCA) Collaborative Group.

HIV Med. 2018 Oct;19(9):619-628. doi: 10.1111/hiv.12640. Epub 2018 Jun 22.

PMID:
29932313
9.

Corrigendum: Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.

Varesano S, Zocchi MR, Poggi A.

Front Immunol. 2018 Jun 13;9:1343. doi: 10.3389/fimmu.2018.01343. eCollection 2018.

10.

Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.

Poggi A, Varesano S, Zocchi MR.

Front Immunol. 2018 Jun 11;9:1342. doi: 10.3389/fimmu.2018.01342. eCollection 2018.

11.

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.

Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.

Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.

12.

Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.

Varesano S, Zocchi MR, Poggi A.

Front Immunol. 2018 May 8;9:998. doi: 10.3389/fimmu.2018.00998. eCollection 2018. Erratum in: Front Immunol. 2018 Jun 13;9:1343.

13.

Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells.

Tosetti F, Venè R, Camodeca C, Nuti E, Rossello A, D'Arrigo C, Galante D, Ferrari N, Poggi A, Zocchi MR.

Oncoimmunology. 2018 Jan 19;7(5):e1421889. doi: 10.1080/2162402X.2017.1421889. eCollection 2018.

14.

How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.

Poggi A, Varesano S, Zocchi MR.

Front Immunol. 2018 Feb 19;9:262. doi: 10.3389/fimmu.2018.00262. eCollection 2018. Review. Erratum in: Front Immunol. 2018 Jun 11;9:1342.

15.

SIRT6 inhibitors with salicylate-like structure show immunosuppressive and chemosensitizing effects.

Damonte P, Sociali G, Parenti MD, Soncini D, Bauer I, Boero S, Grozio A, Holtey MV, Piacente F, Becherini P, Sanguineti R, Salis A, Damonte G, Cea M, Murone M, Poggi A, Nencioni A, Del Rio A, Bruzzone S.

Bioorg Med Chem. 2017 Oct 15;25(20):5849-5858. doi: 10.1016/j.bmc.2017.09.023. Epub 2017 Sep 19.

PMID:
28958848
16.

Identification of peripheral blood involvement in dogs with large B-cell lymphoma: Comparison of different methods.

Riondato F, Martini V, Poggi A, Massaglia I, Comazzi S, Borrelli A, Miniscalco B.

Res Vet Sci. 2017 Dec;115:288-293. doi: 10.1016/j.rvsc.2017.05.027. Epub 2017 May 31.

PMID:
28595084
17.

Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.

Martini V, Cozzi M, Aricò A, Dalla Rovere G, Poggi A, Albonico F, Mortarino M, Ciusani E, Aresu L, Comazzi S.

Vet Immunol Immunopathol. 2017 May;187:14-19. doi: 10.1016/j.vetimm.2017.03.006. Epub 2017 Mar 25.

PMID:
28494924
18.

The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.

Brizzolara A, Benelli R, Venè R, Barboro P, Poggi A, Tosetti F, Ferrari N.

Cancer Lett. 2017 Aug 1;400:9-17. doi: 10.1016/j.canlet.2017.04.025. Epub 2017 Apr 25.

PMID:
28450158
19.

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A, Poggi A.

Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017.

20.

The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cells.

Balza E, Zanellato S, Poggi A, Reverberi D, Rubartelli A, Mortara L.

Eur J Immunol. 2017 Apr;47(4):743-753. doi: 10.1002/eji.201646544. Epub 2017 Mar 6.

21.

Effects on Energy Metabolism of Two Guanidine Molecules, (Boc)2 -Creatine and Metformin.

Garbati P, Ravera S, Scarfì S, Salis A, Rosano C, Poggi A, Damonte G, Millo E, Balestrino M.

J Cell Biochem. 2017 Sep;118(9):2700-2711. doi: 10.1002/jcb.25914. Epub 2017 Feb 13.

PMID:
28128472
22.

The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells.

Penna I, Gigoni A, Costa D, Vella S, Russo D, Poggi A, Villa F, Brizzolara A, Canale C, Mescola A, Daga A, Russo C, Nizzari M, Florio T, Menichini P, Pagano A.

Oncotarget. 2017 Jan 31;8(5):8189-8205. doi: 10.18632/oncotarget.14138.

23.

Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing.

Papait A, Cancedda R, Mastrogiacomo M, Poggi A.

J Tissue Eng Regen Med. 2018 Jan;12(1):30-43. doi: 10.1002/term.2361. Epub 2017 May 11.

PMID:
27863082
24.

Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment.

Poggi A, Giuliani M.

Vaccines (Basel). 2016 Nov 8;4(4). pii: E41. Review.

26.

"Wide-narrow-wide" QRS complex tachycardia: What is the mechanism?

Carbone V, Poggi A, Marafioti V, Oreto G.

Heart Rhythm. 2016 Oct;13(10):2095-7. doi: 10.1016/j.hrthm.2016.06.011. No abstract available.

PMID:
27659255
27.

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing.

Zocchi MR, Camodeca C, Nuti E, Rossello A, Venè R, Tosetti F, Dapino I, Costa D, Musso A, Poggi A.

Oncoimmunology. 2015 Dec 29;5(5):e1123367. doi: 10.1080/2162402X.2015.1123367. eCollection 2016 May.

28.

CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.

Roncella S, Laurent S, Fontana V, Ferro P, Franceschini MC, Salvi S, Varesano S, Boccardo S, Vigani A, Morabito A, Canessa PA, Giannoni U, Rosenberg I, Valentino A, Fedeli F, Merlo DF, Ceppi M, Riggio S, Romani M, Saverino D, Poggi A, Pistillo MP.

Cancer Immunol Immunother. 2016 Aug;65(8):909-17. doi: 10.1007/s00262-016-1844-3. Epub 2016 May 20.

PMID:
27207606
29.

Identification of a suitable internal control for fluorescence analysis on canine peripheral blood samples.

Riondato F, Martini V, Poggi A, Rota A, Comazzi S, Sulce M, Bruno B, Borrelli A, Miniscalco B.

Vet Immunol Immunopathol. 2016 Apr;172:38-42. doi: 10.1016/j.vetimm.2016.03.007. Epub 2016 Mar 6.

PMID:
27032501
30.

Processing-Induced Electrically Active Defects in Black Silicon Nanowire Devices.

Carapezzi S, Castaldini A, Mancarella F, Poggi A, Cavallini A.

ACS Appl Mater Interfaces. 2016 Apr 27;8(16):10443-50. doi: 10.1021/acsami.6b00600. Epub 2016 Apr 14.

PMID:
26979506
31.

Anion Binding by Dimetallic Nickel(II) and Nickel(III) Complexes of a Face-to-Face Bicyclam: Looking for a Bimacrocyclic Effect.

Boiocchi M, Fabbrizzi L, Fusco N, Invernici M, Licchelli M, Poggi A.

Inorg Chem. 2016 Mar 21;55(6):2946-59. doi: 10.1021/acs.inorgchem.5b02826. Epub 2016 Mar 1.

PMID:
26930304
32.

Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models.

Camodeca C, Nuti E, Tepshi L, Boero S, Tuccinardi T, Stura EA, Poggi A, Zocchi MR, Rossello A.

Eur J Med Chem. 2016 Mar 23;111:193-201. doi: 10.1016/j.ejmech.2016.01.053. Epub 2016 Jan 29.

PMID:
26871660
33.

Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP.

J Transl Med. 2016 Jan 22;14:24. doi: 10.1186/s12967-016-0779-y. No abstract available.

34.

Prognostic significance of Ki67 evaluated by flow cytometry in dogs with high-grade B-cell lymphoma.

Poggi A, Miniscalco B, Morello E, Gattino F, Delaude A, Ferrero Poschetto L, Aresu L, Gelain ME, Martini V, Comazzi S, Riondato F.

Vet Comp Oncol. 2017 Jun;15(2):431-440. doi: 10.1111/vco.12184. Epub 2016 Jan 21.

PMID:
26792094
35.

Sirt6 regulates dendritic cell differentiation, maturation, and function.

Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, Monacelli F, Odetti P, Ballestrero A, Uccelli A, Mostoslavsky R, Poggi A, Nencioni A.

Aging (Albany NY). 2016 Jan;8(1):34-49.

36.

Analytical and diagnostic validation of a flow cytometric strategy to quantify blood and marrow infiltration in dogs with large B-cell lymphoma.

Riondato F, Miniscalco B, Poggi A, Aricò A, Aresu L, Comazzi S, Martini V.

Cytometry B Clin Cytom. 2016 Nov;90(6):525-530. doi: 10.1002/cyto.b.21353. Epub 2016 Feb 3.

37.

Combined platelet and plasma derivatives enhance proliferation of stem/progenitor cells maintaining their differentiation potential.

Muraglia A, Todeschi MR, Papait A, Poggi A, Spanò R, Strada P, Cancedda R, Mastrogiacomo M.

Cytotherapy. 2015 Dec;17(12):1793-806. doi: 10.1016/j.jcyt.2015.09.004.

PMID:
26589754
38.

Copper(II) Complexes of Cyclams Containing Nitrophenyl Substituents: Push-Pull Behavior and Scorpionate Coordination of the Nitro Group.

Boiocchi M, Ciarrocchi C, Fabbrizzi L, Licchelli M, Mangano C, Poggi A, Vázquez López M.

Inorg Chem. 2015 Nov 2;54(21):10197-207. doi: 10.1021/acs.inorgchem.5b01273. Epub 2015 Oct 15.

PMID:
26468764
39.

Chronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs.

Comazzi S, Martini V, Riondato F, Poggi A, Stefanello D, Marconato L, Albonico F, Gelain ME.

Vet Comp Oncol. 2017 Jun;15(2):366-373. doi: 10.1111/vco.12172. Epub 2015 Oct 14.

PMID:
26463596
40.

Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP.

J Transl Med. 2015 Oct 8;13:324. doi: 10.1186/s12967-015-0680-0. Erratum in: J Transl Med. 2016;14:24.

41.

Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics.

Sociali G, Galeno L, Parenti MD, Grozio A, Bauer I, Passalacqua M, Boero S, Donadini A, Millo E, Bellotti M, Sturla L, Damonte P, Puddu A, Ferroni C, Varchi G, Franceschi C, Ballestrero A, Poggi A, Bruzzone S, Nencioni A, Del Rio A.

Eur J Med Chem. 2015 Sep 18;102:530-9. doi: 10.1016/j.ejmech.2015.08.024. Epub 2015 Aug 14.

PMID:
26310895
42.

Canine small clear cell/T-zone lymphoma: clinical presentation and outcome in a retrospective case series.

Martini V, Marconato L, Poggi A, Riondato F, Aresu L, Cozzi M, Comazzi S.

Vet Comp Oncol. 2016 Aug;14 Suppl 1:117-26. doi: 10.1111/vco.12155. Epub 2015 Jun 3.

PMID:
26040658
43.

Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.

Venè R, Tosetti F, Minghelli S, Poggi A, Ferrari N, Benelli R.

Oncotarget. 2015 May 20;6(14):12310-25.

44.

Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.

Montecucco F, Lenglet S, Carbone F, Boero S, Pelli G, Burger F, Roth A, Bertolotto M, Nencioni A, Cea M, Dallegri F, Fraga-Silva RA, Fougère L, Elfakir C, Gassner AL, Rudaz S, Parissaux X, Wils D, Salomé M, Vuilleumier N, Poggi A, Mach F.

Vascul Pharmacol. 2015 Sep;72:197-208. doi: 10.1016/j.vph.2015.04.008. Epub 2015 Apr 25.

PMID:
25921922
45.

Mesenchymal stromal cells as regulators of anti-tumour immune response.

Poggi A, Zocchi MR.

Indian J Med Res. 2015 Feb;141(2):139-42. No abstract available.

46.

Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.

Borsini F, Bordi F, Poggi A, Di Matteo V.

J Psychopharmacol. 2015 Jul;29(7):802-11. doi: 10.1177/0269881115573804. Epub 2015 Mar 3.

PMID:
25735994
47.

Oxo-anion recognition by mono- and bisurea pendant-arm macrocyclic complexes.

Boiocchi M, Licchelli M, Milani M, Poggi A, Sacchi D.

Inorg Chem. 2015 Jan 5;54(1):47-58. doi: 10.1021/ic501527k. Epub 2014 Dec 22.

PMID:
25529826
48.

γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy.

Poggi A, Zocchi MR.

Front Immunol. 2014 Nov 11;5:575. doi: 10.3389/fimmu.2014.00575. eCollection 2014. Review.

49.

Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.

Soncini D, Caffa I, Zoppoli G, Cea M, Cagnetta A, Passalacqua M, Mastracci L, Boero S, Montecucco F, Sociali G, Lasigliè D, Damonte P, Grozio A, Mannino E, Poggi A, D'Agostino VG, Monacelli F, Provenzani A, Odetti P, Ballestrero A, Bruzzone S, Nencioni A.

J Biol Chem. 2014 Dec 5;289(49):34189-204. doi: 10.1074/jbc.M114.594721. Epub 2014 Oct 20.

50.

Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.

Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F.

Neoplasia. 2014 Sep;16(9):710-22. doi: 10.1016/j.neo.2014.07.012.

Supplemental Content

Support Center